EUVIMEDEUVIMED entdecken
Open Access

Plant-Derived Extracellular Vesicles Delivered by Microinfusion Microneedling for Androgenetic Alopecia: A Retrospective Case Series

Francisco José Rodríguez-Cuadrado, Adrián Imbernón-Moya, Patricia Burgos-Blasco, Masiel García-Fernández, Marina Barletta

Skin Appendage Disorders · 03.07.2026 · 1-7

DOI: 10.1159/000553389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Appendage Disorders, online erschienen am 03.07.2026. Verfasst von Francisco José Rodríguez-Cuadrado und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hair Disorders and Hair Transplant Unit, Dermatology, Grupo Pedro Jaén, Madrid, Spain. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Extracellular vesicles (EVs), often referred to in the literature as “exosomes,” have emerged as candidate biologic mediators for hair restoration, but clinical evidence remains limited. Microinfusion of drugs into the skin (MMP®) is a tattoo device-based technique that combines microneedling with controlled intradermal delivery and may offer a reproducible way to administer scalp treatments.

Methods

We performed a retrospective case series of adults with androgenetic alopecia (AGA) treated with a plant-derived EV formulation delivered through MMP®. Patients underwent 6 monthly sessions. Treatment tolerance, patient-reported outcomes, and blinded investigator assessments from standardized clinical photographs and site-matched trichoscopy were reviewed.

Results

Twenty patients were included. Tolerance was favorable: 85% reported no adverse effects and 15% reported mild procedural pain. Subjectively, 95% of patients perceived improvement after six sessions, including 55% who reported marked improvement. Blinded evaluation also suggested benefit, more clearly at the clinical level than at the trichoscopic level. Mean clinical ratings indicated mild-to-marked improvement in 70% of cases, whereas mean trichoscopic ratings indicated mild-to-marked improvement in 50% and stabilization-to-mild improvement in 45%.

Conclusion

In this retrospective series, plant-derived EVs delivered by MMP® were feasible, well tolerated, and associated with favorable subjective and blinded efficacy signals in patients with AGA.

Schlagwörter

Stichwörter der Autor:innen

Androgenetic alopeciaExosomesExtracellular vesiclesMicroinfusion of drugs into the skinMicroneedling

Autor:innen und Institutionen

  • Hair Disorders and Hair Transplant Unit, Dermatology, Grupo Pedro Jaén, Madrid, Spain.
  • Dermatology Department, Hospital Universitario Severo Ochoa, Madrid, Spain.
  • Dermatology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Private Practice, São Paulo, Brazil.
  • Clínica Marina Barletta, São Paulo, Brazil.

Zitieren

APA

Rodríguez-Cuadrado, F. J., Imbernón-Moya, A., Burgos-Blasco, P., García-Fernández, M., & Barletta, M. (2026). Plant-Derived Extracellular Vesicles Delivered by Microinfusion Microneedling for Androgenetic Alopecia: A Retrospective Case Series. Skin Appendage Disorders, 1-7. https://doi.org/10.1159/000553389

Vancouver

Rodríguez-Cuadrado FJ, Imbernón-Moya A, Burgos-Blasco P, García-Fernández M, Barletta M. Plant-Derived Extracellular Vesicles Delivered by Microinfusion Microneedling for Androgenetic Alopecia: A Retrospective Case Series. Skin Appendage Disorders. 2026:1-7. doi:10.1159/000553389

BibTeX
@article{RodrguezCuadrado2026,
  author = {Rodríguez-Cuadrado, Francisco José and Imbernón-Moya, Adrián and Burgos-Blasco, Patricia and García-Fernández, Masiel and Barletta, Marina},
  title = {Plant-Derived Extracellular Vesicles Delivered by Microinfusion Microneedling for Androgenetic Alopecia: A Retrospective Case Series},
  journal = {Skin Appendage Disorders},
  year = {2026},
  pages = {1--7},
  doi = {10.1159/000553389}
}
Kostenlos starten →